Delivery Order SPE2DB22D2108-SPE2DB25FU5DM
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Eliquis 5 mg tablets (60-count packages) valued at $25,897.33. This non-set-aside, competitively awarded contract represents a firm fixed-price delivery order with an ultimate completion date of July 25, 2025. The award is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order from the Defense Logistics Agency (DLA) on August 13, 2025, for Eliquis 5 mg tablets in a 60-count package. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $10,815.81 and is set to be completed by August 14, 2025. The contract represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Eliquis 5 mg tablets in quantities of 60 units, with a ceiling value of $9,366.47. This competitive, firm fixed-price delivery order is expected to be completed by August 8, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order issued under AmerisourceBergen's larger Indefinite...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Eliquis 5 mg tablets (60-count packages) with a ceiling value of $18,978.90. This non-set-aside competitive award is scheduled for completion by August 8, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under the company's...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a firm fixed-price delivery order by the Defense Logistics Agency on July 24, 2025, for 60 tablets of Eliquis 2.5 mg with a ceiling value of $1,989.38. This non-competitive delivery order is set to be completed by July 25, 2025, and represents a pharmaceutical supply requisition under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. The contract award supports the Defense...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Eliquis 5 mg tablets (60-count packaging) under a firm fixed-price contract valued at $2,409.35. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The contract carries no set-aside designation, indicating it...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Eliquis 5 mg tablets (60-count units) at a firm fixed price ceiling value of $25,069.77. This non-set-aside, competitively awarded contract is scheduled for completion by August 15, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Eliquis 5 mg tablets in quantities of 60 units. This firm fixed-price delivery order carries a ceiling value of $22,359.33 and is scheduled for ultimate completion by August 11, 2025. The contract was competitively awarded without set-aside provisions and will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Eliquis 5 mg tablets (60-count packages) with a contract value of $13,165.20. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The order is set for ultimate completion by July 29, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a $25,827.06 delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Eliquis 5 mg tablets in quantities of 60 per package. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 13, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary headquarters and...
- SPE2DB22D2108Indefinite Delivery Contract
- SPE2DB22D2108-SPE2DB25FU5DMDelivery Order
On July 18, 2025, the Defense Logistics Agency (DLA) awarded a delivery order valued at $1,965.60 to AmerisourceBergen Drug Corp for the supply of Eliquis 2.5 mg tablets (60-count units). The contract, executed on a firm fixed-price basis with no set-aside designation, is scheduled for completion by July 21, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills this order through its corporate office location. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.99 million through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare systems. The award reflects AmerisourceBergen's established role as a critical federal medical procurement vendor for the Defense Health Agency and military healthcare programs. Eliquis is an anticoagulant medication essential for thromboembolism prevention and stroke reduction in atrial fibrillation patients, making it a strategic pharmaceutical commodity within the military healthcare supply chain. The competitively awarded delivery order demonstrates the vendor's capability to meet federal procurement requirements for brand-name medications across multiple therapeutic domains. AmerisourceBergen's extensive contract portfolio with DLA encompasses a diverse range of pharmaceutical products and medical supplies supporting military personnel and veteran healthcare systems worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 7/18/25 |